Idiopathic pulmonary fibrosis Trials in Cottingham, United Kingdom
Conditions / Idiopathic pulmonary fibrosis / Cottingham, United Kingdom
Research into Idiopathic pulmonary fibrosis spans multiple therapeutic approaches and trial phases.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03711162 | A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care | TERMINATED | PHASE3 |
| NCT02699879 | Evaluation of Long-Term Safety of Pirfenidone (Esbriet) in Participants With Idiopathic Pulmonary Fibrosis (IPF) | COMPLETED | — |
| NCT01769196 | Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) | TERMINATED | PHASE2 |
| NCT03142191 | A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis | TERMINATED | PHASE2 |
| NCT06132256 | MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF) | RECRUITING | PHASE2 |
| NCT06003426 | A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04030026 | A Study of Nalbuphine (Extended Release) ER in Idiopathic Pulmonary Fibrosis (IPF) for Treatment of Cough | COMPLETED | PHASE2 |
| NCT05185089 | Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis | COMPLETED | PHASE2 |
| NCT06097260 | Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis | TERMINATED | PHASE2 |
| NCT05964335 | Cough Reduction in IPF With Nalbuphine ER | COMPLETED | PHASE2 |